[
  {
    "text": "(i) the number of units of such SKU of the Product shipped from the Specialty Pharmacies to all patients based on prescriptions.",
    "bbox": [
      117,
      141,
      1000,
      155
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "written by the Specialty in the Territory during an applicable period (as determined by data reported pursuant to agreements",
    "bbox": [
      117,
      160,
      1000,
      174
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "between Dova (or its Affiliates) and the Specialty Pharmacies or the data aggregators, as applicable); and",
    "bbox": [
      116,
      179,
      1000,
      193
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "MULTIPLIED BY",
    "bbox": [
      181,
      215,
      339,
      225
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(ii) the applicable WAC for such SKU of the Product for the applicable period",
    "bbox": [
      118,
      249,
      785,
      263
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "MULTIPLIED BY",
    "bbox": [
      116,
      284,
      276,
      295
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(iii) the Gross to Net Fraction for such SKU of the Product for the applicable period.",
    "bbox": [
      117,
      319,
      836,
      333
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.59 \"Specialty Pharmacy'' shall mean those specialty pharmacies to which Dova (or its Affiliates) sells and/or ships units",
    "bbox": [
      181,
      355,
      1000,
      367
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "of Product during the Term and for which Dova or its Affiliates have agreements with that include data provisions or provide for",
    "bbox": [
      112,
      373,
      1000,
      388
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "separate data agreements which enables Dova to track shipments of Product from such Specialty Pharmacy to patients based on",
    "bbox": [
      112,
      393,
      1000,
      407
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "the Target Professional prescribing such Product..",
    "bbox": [
      113,
      413,
      526,
      426
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.60 \"Tail Period\"' shall mean the period commencing on the day after the last day of the Term and ending on the earlier of",
    "bbox": [
      180,
      447,
      1000,
      461
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(i) [***] and (ii) [***], unless terminated early pursuant to Section 2.3.1(a) of the Agreement.",
    "bbox": [
      113,
      466,
      907,
      482
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.61 \"Target Professionals\" shall mean physicians, nurse practitioners, physician assistants and any other medical",
    "bbox": [
      180,
      502,
      1000,
      516
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "professionals in the Territory with prescribing authority (as authorized under Applicable Law) in the Territory for the Product.",
    "bbox": [
      114,
      523,
      1000,
      535
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.62 \"Term\"' shall have the meaning set forth in Section 12.1..",
    "bbox": [
      180,
      556,
      696,
      570
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.63 \"Territory'' shall mean the United States of America and its territories and possessions.",
    "bbox": [
      180,
      592,
      962,
      607
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.64 \"Third Party(ies)\"' shall mean any person or entity other than Dova and Valeant and their respective Affiliates",
    "bbox": [
      181,
      628,
      1000,
      643
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.65 \"Third Party Agreements\" shall mean the agreements described on Schedule 1.65 hereto.",
    "bbox": [
      181,
      665,
      1000,
      679
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.66 Valeant Activities\"' shall mean any and all promotional activities (including Detailing) conducted by Valeant to",
    "bbox": [
      179,
      700,
      1000,
      715
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "encourage the appropriate use of the Product in the Specialty in the Field in the Territory in accordance with the terms of this",
    "bbox": [
      112,
      721,
      1000,
      734
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Agreement.",
    "bbox": [
      112,
      740,
      209,
      752
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.67 \"Valeant Property\" shall have the meaning set forth in Section 8.1.1.",
    "bbox": [
      181,
      774,
      812,
      788
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.68 \"WAC\" shall mean, for each SKU of the Product, Dova's list price for a unit of the SKU of the Product to",
    "bbox": [
      179,
      810,
      1000,
      825
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "wholesalers or direct purchasers in the Territory, as reported in wholesale price guides or other nationally recognized publications",
    "bbox": [
      112,
      830,
      1000,
      845
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "of drug pricing data.n.",
    "bbox": [
      112,
      849,
      281,
      864
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ARTICLE 2",
    "bbox": [
      608,
      884,
      722,
      897
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "RIGHTS AND OBLIGATIONS",
    "bbox": [
      516,
      905,
      816,
      917
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "2.1 Engagement; Grant of Rights. During the Term, subject to the terms and conditions of this Agreement, Dova",
    "bbox": [
      179,
      939,
      1000,
      953
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "hereby grants to Valeant the right, on a co-exclusive basis (solely with Dova and its Affiliates), to Detail and promote the Product",
    "bbox": [
      111,
      959,
      1000,
      974
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "in the Specialty in the Territory in the Field, and to conduct the Valeant Activities and the activities of the institutional account",
    "bbox": [
      113,
      980,
      1000,
      992
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "management team (pursuant to and subject to the terms of Section 4.1.5) for the Product in the Territory in the Field in accordance",
    "bbox": [
      110,
      997,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "with the terms and conditions of this Agreement. Notwithstanding the foregoing, Dova retains and reserves the right for Dova and",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "its Affiliates to promote the Product in the Territory including in the Specialty. Valeant shall have no other rights relating to the",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Product, except as specifically set forth in this Agreement and, without limiting the foregoing, except as set out in Section 4.1.5, if",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "agreed upon, Valeant shall have no right to, and shall not, conduct the Valeant Activities for the Product outside the Specialty or",
    "bbox": [
      112,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "outside the Territory or for use outside the Field. Except to Affiliates of Valeant, Valeant's rights and obligations under this Section",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "2.1 are non-transferable, non-assignable, and non-delegable. Except to Affiliates of Valeant, Valeant shall not subcontract the",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Valeant Activities with any Third Party (including any contract sales force). Any obligation of Valeant under or pursuant to this.",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Agreement may be satisfied, met or fulfilled, in whole or in part, at Valeant's sole and exclusive option, either by Valeant or its",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Affiliates. Valeant guarantees the performance of all actions, agreements and obligations to be performed by its Affiliates under the",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "terms and conditions of this Agreement. For clarity, Valeant shall not have any license rights hereunder nor any rights to sublicense",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "any rights hereunder.",
    "bbox": [
      113,
      1000,
      285,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      592,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(i) the number of units of such SKU of the Product shipped from the Specialty Pharmacies to all patients based on prescriptions.",
    "bbox": [
      117,
      141,
      1000,
      155
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "written by the Specialty in the Territory during an applicable period (as determined by data reported pursuant to agreements",
    "bbox": [
      117,
      160,
      1000,
      174
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "between Dova (or its Affiliates) and the Specialty Pharmacies or the data aggregators, as applicable); and",
    "bbox": [
      116,
      179,
      1000,
      193
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "MULTIPLIED BY",
    "bbox": [
      181,
      215,
      339,
      225
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "(ii) the applicable WAC for such SKU of the Product for the applicable period",
    "bbox": [
      118,
      249,
      785,
      263
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "MULTIPLIED BY",
    "bbox": [
      116,
      284,
      276,
      295
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "(iii) the Gross to Net Fraction for such SKU of the Product for the applicable period.",
    "bbox": [
      117,
      319,
      836,
      333
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.59 \"Specialty Pharmacy'' shall mean those specialty pharmacies to which Dova (or its Affiliates) sells and/or ships units",
    "bbox": [
      181,
      355,
      1000,
      367
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "of Product during the Term and for which Dova or its Affiliates have agreements with that include data provisions or provide for",
    "bbox": [
      112,
      373,
      1000,
      388
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "separate data agreements which enables Dova to track shipments of Product from such Specialty Pharmacy to patients based on",
    "bbox": [
      112,
      393,
      1000,
      407
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "the Target Professional prescribing such Product..",
    "bbox": [
      113,
      413,
      526,
      426
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.60 \"Tail Period\"' shall mean the period commencing on the day after the last day of the Term and ending on the earlier of",
    "bbox": [
      180,
      447,
      1000,
      461
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "(i) [***] and (ii) [***], unless terminated early pursuant to Section 2.3.1(a) of the Agreement.",
    "bbox": [
      113,
      466,
      907,
      482
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.61 \"Target Professionals\" shall mean physicians, nurse practitioners, physician assistants and any other medical",
    "bbox": [
      180,
      502,
      1000,
      516
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "professionals in the Territory with prescribing authority (as authorized under Applicable Law) in the Territory for the Product.",
    "bbox": [
      114,
      523,
      1000,
      535
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.62 \"Term\"' shall have the meaning set forth in Section 12.1..",
    "bbox": [
      180,
      556,
      696,
      570
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.63 \"Territory'' shall mean the United States of America and its territories and possessions.",
    "bbox": [
      180,
      592,
      962,
      607
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.64 \"Third Party(ies)\"' shall mean any person or entity other than Dova and Valeant and their respective Affiliates",
    "bbox": [
      181,
      628,
      1000,
      643
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.65 \"Third Party Agreements\" shall mean the agreements described on Schedule 1.65 hereto.",
    "bbox": [
      181,
      665,
      1000,
      679
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.66 Valeant Activities\"' shall mean any and all promotional activities (including Detailing) conducted by Valeant to",
    "bbox": [
      179,
      700,
      1000,
      715
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "encourage the appropriate use of the Product in the Specialty in the Field in the Territory in accordance with the terms of this",
    "bbox": [
      112,
      721,
      1000,
      734
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Agreement.",
    "bbox": [
      112,
      740,
      209,
      752
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.67 \"Valeant Property\" shall have the meaning set forth in Section 8.1.1.",
    "bbox": [
      181,
      774,
      812,
      788
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.68 \"WAC\" shall mean, for each SKU of the Product, Dova's list price for a unit of the SKU of the Product to",
    "bbox": [
      179,
      810,
      1000,
      825
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "wholesalers or direct purchasers in the Territory, as reported in wholesale price guides or other nationally recognized publications",
    "bbox": [
      112,
      830,
      1000,
      845
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "of drug pricing data.n.",
    "bbox": [
      112,
      849,
      281,
      864
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "ARTICLE 2",
    "bbox": [
      608,
      884,
      722,
      897
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "RIGHTS AND OBLIGATIONS",
    "bbox": [
      516,
      905,
      816,
      917
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "2.1 Engagement; Grant of Rights. During the Term, subject to the terms and conditions of this Agreement, Dova",
    "bbox": [
      179,
      939,
      1000,
      953
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "hereby grants to Valeant the right, on a co-exclusive basis (solely with Dova and its Affiliates), to Detail and promote the Product",
    "bbox": [
      111,
      959,
      1000,
      974
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "in the Specialty in the Territory in the Field, and to conduct the Valeant Activities and the activities of the institutional account",
    "bbox": [
      113,
      980,
      1000,
      992
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "management team (pursuant to and subject to the terms of Section 4.1.5) for the Product in the Territory in the Field in accordance",
    "bbox": [
      110,
      997,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "with the terms and conditions of this Agreement. Notwithstanding the foregoing, Dova retains and reserves the right for Dova and",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "its Affiliates to promote the Product in the Territory including in the Specialty. Valeant shall have no other rights relating to the",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Product, except as specifically set forth in this Agreement and, without limiting the foregoing, except as set out in Section 4.1.5, if",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "agreed upon, Valeant shall have no right to, and shall not, conduct the Valeant Activities for the Product outside the Specialty or",
    "bbox": [
      112,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "outside the Territory or for use outside the Field. Except to Affiliates of Valeant, Valeant's rights and obligations under this Section",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "2.1 are non-transferable, non-assignable, and non-delegable. Except to Affiliates of Valeant, Valeant shall not subcontract the",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Valeant Activities with any Third Party (including any contract sales force). Any obligation of Valeant under or pursuant to this.",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Agreement may be satisfied, met or fulfilled, in whole or in part, at Valeant's sole and exclusive option, either by Valeant or its",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Affiliates. Valeant guarantees the performance of all actions, agreements and obligations to be performed by its Affiliates under the",
    "bbox": [
      111,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "terms and conditions of this Agreement. For clarity, Valeant shall not have any license rights hereunder nor any rights to sublicense",
    "bbox": [
      113,
      1000,
      1000,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "any rights hereunder.",
    "bbox": [
      113,
      1000,
      285,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      592,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  }
]